Evidence map›Paper›PMID 31426764›Full record

Observational studyBMC geriatrics2019

Health of Spanish centenarians: a cross-sectional study based on electronic health records.

Antonio Gimeno-Miguel, Mercedes Clerencia-Sierra, Ignatios Ioakeim, Beatriz Poblador-Plou, Mercedes Aza-Pascual-Salcedo, Francisca González-Rubio, Raquel Rodríguez Herrero, Alexandra Prados-Torres

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC geriatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.International journal of environmental research and public health · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Antonio Gimeno-MiguelEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain. agimenomi.iacs@aragon.es.ORCID 0000-0002-5440-1710
Mercedes Clerencia-SierraEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Ignatios IoakeimEpiChron Research Group on Chronic Diseases, IIS Aragón, Zaragoza, Spain.
Beatriz Poblador-PlouEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Mercedes Aza-Pascual-SalcedoEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Francisca González-RubioEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Raquel Rodríguez HerreroAragon Health Service (SALUD), Miguel Servet University Hospital, Zaragoza, Spain.
Alexandra Prados-TorresEpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, REDISSEC, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón · ESServicio Aragonés de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the number of centenarians increasing exponentially in Spain, a deeper knowledge of their socio-demographic, clinical, and healthcare use characteristics is important to better understand the health profile of the very elderly.

methodsWe conducted a retrospective, cross-sectional observational study in the EpiChron Cohort (Aragón, Spain) aimed at analyzing the socio-demographic, clinical, drug use and healthcare use characteristics of 1680 centenarians during 2011-2015, using data from electronic health records and clinical-administrative databases.

resultsSpanish centenarians (79.1% women) had 101.6 years on average. Approximately 80% of centenarians suffered from multimorbidity, with an average of 4.0 chronic conditions; 50% were exposed to polypharmacy, with an average of 4.8 medications; only 6% of centenarians were free of chronic diseases and only 7% were not on medication. Centenarians presented a cardio-cerebrovascular pattern in which hypertension, heart failure, cerebrovascular disease and dementia were the most frequent conditions. Primary care was the most frequently visited healthcare level (79% of them), followed by medical specialist consultations (23%), hospitalizations (13%), and emergency service use (9%).

conclusionsMultimorbidity is the rule rather than the exception in Spanish centenarians. Addressing medical care in the very elderly from a holistic geriatric view is critical in order to preserve their health, and avoid the negative effects of polypharmacy.

Indexed as

Health StatusAged, 80 and overCardiovascular DiseasesChronic DiseaseCohort StudiesCross-Sectional StudiesDatabases, FactualDementiaElectronic Health RecordsEmergency Service, HospitalFemaleHospitalizationHumansMaleMultimorbidityPolypharmacyCentenariansHealthcare useMultimorbidityPolypharmacySpain

Identifiers

PMID31426764
PMCPMC6701024
OpenAlexW2969264344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.